Gene Expression and Ketamine Response in Subjects With Treatment-Resistant Depression

被引：0
|
作者：
Mohazzab-Hosseinian, Sahra [1 ]
Kadriu, Bashkim [1 ]
Zandi, Peter [1 ]
Zarate, Carlos [1 ]
Goes, Fernando [1 ]
机构：
[1] Johns Hopkins Sch Med, Baltimore, MD USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2019年 / 44卷 / SUPPL 1期
关键词：
Biomarker; Ketamine; Treatment Resistant Depression;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T164
引用
收藏
页码：318 / 319
页数：2
相关论文
共 50 条
  • [31] Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review
    Romeo, B.
    Choucha, W.
    Fossati, P.
    Rotge, J. -Y.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (04): : 354 - 362
  • [32] Biomarkers of the rapid clinical response to ketamine in treatment-resistant depression: focus on kynurenine
    Clarke, G.
    Naughton, M.
    O'Shea, R.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    Cryan, J. F.
    Dinan, T. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S460 - S460
  • [33] Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
    Niciu, Mark J.
    Shovestul, Bridget J.
    Jaso, Brittany A.
    Farmer, Cristan
    Luckenbaugh, David A.
    Brutsche, Nancy E.
    Park, Lawrence T.
    Ballard, Elizabeth D.
    Zarat, Carlos A., Jr.
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 232 : 310 - 315
  • [34] Functional Connectivity and Response to Ketamine Therapy in Treatment-Resistant Depression: A Pilot Study
    Vasavada, Megha
    Leaver, Amber
    Loureiro, Joana
    Espinoza, Randall
    Joshi, Shantanu
    Njau, Stephanie
    Wade, Benjamin
    Kubicki, Antoni
    Congdon, Eliza
    Narr, Katherine
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S292 - S292
  • [35] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    Murrough, James W.
    Wan, Le-Ben
    Iacoviello, Brian
    Collins, Katherine A.
    Solon, Carly
    Glicksberg, Benjamin
    Perez, Andrew M.
    Mathew, Sanjay J.
    Charney, Dennis S.
    Iosifescu, Dan V.
    Burdick, Katherine E.
    PSYCHOPHARMACOLOGY, 2014, 231 (03) : 481 - 488
  • [36] Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression
    Slupski, Jakub
    Cubala, Wieslaw Jerzy
    Gorska, Natalia
    Slupska, Anita
    Galuszko-Wegielnik, Maria
    BRAIN SCIENCES, 2020, 10 (12) : 1 - 9
  • [37] Ketamine is effective in an animal model of treatment-resistant depression
    Pereira, V.
    Joca, S.
    Wegener, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S373 - S373
  • [38] Ketamine for Treatment-Resistant Unipolar Depression Current Evidence
    Mathew, Sanjay J.
    Shah, Asim
    Lapidus, Kyle
    Clark, Crystal
    Jarun, Noor
    Ostermeyer, Britta
    Murrough, James W.
    CNS DRUGS, 2012, 26 (03) : 189 - 204
  • [39] Use of Ketamine in Elderly Patients with Treatment-Resistant Depression
    Ribeiro, Carolina Medeiros da Frota
    Riva-Posse, Patricio
    CURRENT PSYCHIATRY REPORTS, 2017, 19 (12)
  • [40] Personalized use of ketamine and esketamine for treatment-resistant depression
    Medeiros, Gustavo C.
    Demo, Isabella
    Goes, Fernando S.
    Zarate Jr, Carlos A.
    Gould, Todd D.
    TRANSLATIONAL PSYCHIATRY, 2024, 14 (01):
12345